PTU - Polskie Towarzystwo Urologiczne
list of articles:


Article published in Urologia Polska 1979/32/4.

authors

Andrzej Kaczmarek
Oddział Urologii Szpitala Kolejowego we Wrocławiu
Ordynator Oddziału: dr med. W. Dobrzęcki

references

  1. Abbasian A., Wallace D. M.: Intracavitary chemotherapy of diffuse nonin-filtrating papillary carcinoma of the bladder. J. Urol., 1966, 96, 461.
  2. Barnes R. W.: Bladder tumours treated by endoscopic surgery. Long-term results. — Int. Urol. Nephrol., 1974, 6, 191.
  3. Boyland E.: The biochemistry of cancer of the bladder. Brit. Med. Buli., 1958, 14, 153.
  4. Corrado F. i wsp.: Chemoprophy-laxis of bladder cancer recurrence: immunological aspects. Panminerva Medica, 1974, 16, 85.
  5. Crassweller P. C. i wsp.: The use of nitrogen mustrad for pre-vention of bladder tumor recurrence. J. Urol., 1968, 100, 21.
  6. Drew J. E., Mar­shall V. F.: The effects of topical thiotepa on the recurrence ratę of superficial bladder cancers. J. Urol., 1968, 99, 740.
  7. Es±uival E. L. i wsp.: Treatment of bladder tumours by instillations of Thiotepa and 5-fluorouracyl. Invest. Urol., 1965, 2, 381.
  8. Hinman F.: The recurrence of bladder tumours. J. Urol., 1960, 83, 294.
  9. Ichikawa T. i wsp.: Clinical application of 2,5-bi-O-acetyl-B-glucaro--(1-4) (6-3)-dilactone (SLA) to bladder tumor, with special reference to its effect on fre±uency of tumor recurrences. J. Urol., 1972, 108, 571.
  10. Kirwin T. J.: Papillomatosis of the bladder. New coceptions of etiology and treatment. J. Urol., 1943, 49, 1.
  11. McDonald D. F., Thorson T.: Clinical implications of transplantability of induced bladder tumors to intact epithelium in dogs. J. Urol., 1956, 75, 690.
  12. Miller A. i wsp.: The Bristol bladder tumour registry-Brit. J. Urol., 1969, 41, 1 (suppl.).
  13. Milner W. A.: The role of conservative surgery in the treatment of bladder tumors. Brit. J.Urol., 1954, 26, 375.
  14. Morales A. i wsp.: Intracavi-tary bacillus Calmete-Guerin in treatment of superficial bladder tumors. J. Urol.,. 1976, 116, 180.
  15. Olsson C. A. i wsp.: Immunologie reduetion of bladder can­cer receurence ratę. J. Urol., 1974, 111, 173.
  16. Oravisto K. J.: Topical use of Thio-Tepa for tumours of the bladder. Urol. Int., 1965, 20, 23.
  17. Pavone-Macaluso M. i wsp.: The use of chemotherapeutic agents in the prophylaxis of pa-pillary bladder tumours. Urol. Int., 1971, 26, 379.
  18. Pavone-Macaluso M.: Pre-lilinary evaluation of VM-26. A new epipodophyllotoxin derivative in the treat­ment of uregunital tumours. Eur. Urol., 1975, 1, 54.
  19. Price J. M. i wsp.: Stu­dies on the etiology of carcinoma of the urinary bladder. J. Urol., 1969, 83, 376.
  20. Quenu L.: Le thie-tepa dans le traitement des papillomatoses vesicales. Ann. Urol., 1971, 5, 189.
  21. (tekst nieczytelny) Zytostatika insbesondere ihrer intra-arteriellen Anwendung bei Blasentumoren. Ztschr. Urol., 19TO, 53, Its.
  22. Riches E.: Choice of treatment in carcinoma of the bladder. J. Urol., 1960, 84, 472.
  23. Riddle P. R.: The management of superficial bladder tumours with intravesi-cal Epodyl. Brit. J. Urol., 1973, 45, 84.
  24. Riedel B. i wsp.: Rezidivprophylaxe des Blasenpapilloms mit Thio-TEPA. Der Urologe, 1975, 14, 87.
  25. Schlegel J. V. i wsp.: The role of ascorbinic acid in the prevention of bladder tumour forma-tion. J. Urol., 1970, 103, 155.
  26. Thompson N.: Bladder papilloma. An analysis of 75 cases. Brit. J. Surg., 1960, 47, 419.
  27. Veenema R. J. i wsp.: Thiotepa bladder tumors. J. Urol., 1969, 101, 711.
  28. Vermooten V. i wsp.: Treatment of papillomatosis of bladder with phenol and glycerin. J. Urol., 1968, 99, 588.
  29. Wescot J. W.: The prophylactic use of thio-tepa in transitional cell carcinoma of the bladder. J. Urol., 1966, 96, 913.
  30. Weyrauch H. M., Crossjield J. H.: Dissemination of bladder neoplasms by endoscopic eleetroresection. J. Urol., 1962, 87, 391.

correspondence

ul. Scinawska 4/4
53-642 Wrocław

Praca wpłynęła do Redakcji: 15.XII.1977 r.